Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-17, Stock:ABBV, The news for the past five days is as follows:
2018-05-10: NEWS1: 3 Dividend Stocks for In-the-Know Investors.NEWS2: Exploring AbbVie’s Cash Flows.NEWS3: What’s AbbVie’s Business Strategy for 2018?.NEWS4: Analyzing AbbVie’s Financial Performance.NEWS5: Exploring AbbVie’s Research Programs in Oncology and Neurology.NEWS6: Exploring the Key Aspects of AbbVie’s Research Pipeline.NEWS7: Analyzing AbbVie’s Humira, Imbruvica, and HCV Products.NEWS8: Analyzing AbbVie’s Product Performance.NEWS9: How Much Upside Do Analysts Expect from AbbVie?.NEWS10: Analysts’ Recommendations for Regeneron Pharmaceuticals in May.
2018-05-11: NEWS1: Why Do 113 Top-Rated Funds Own Shares In This Breakout Cloud Stock?.NEWS2: 3 Dividend Stocks for In-the-Know Investors.NEWS3: 3 Dividend Stocks for In-the-Know Investors.
2018-05-14: NEWS1: The Trump Plan To Reduce Prescription Drug Prices Will Have A Major Impact.NEWS2: Vanguard Growth ETF Experiences Big Inflow.NEWS3: Vanguard Growth ETF Experiences Big Inflow.
2018-05-15: NEWS1: Trump’s Attempt to Shame Drugmakers Shows Medicare Costs Soaring.NEWS2: AstraZeneca’s 1Q18 Estimates: Segment-by-Segment Revenues.NEWS3: 3 Top Healthcare Stocks to Buy in May.
2018-05-16: NEWS1: AbbVie to Show Progress and Growth in Oncology Research at the American Society of Clinical Oncology 2018 Annual Meeting.NEWS2: A Look at Gilead Sciences’ Competitive Scenario.

Answer: Rise